
UpDoc is a healthcare technology company pioneering Remote Patient Intervention (RPI), a clinically tested, physician-supervised AI platform that manages chronic diseases through remote patient monitoring and conversational AI. The platform leverages advanced clinical intelligence and multi-LLM conversational interfaces, including partnerships with Microsoft and Google, to improve medication adherence and chronic disease management outcomes. UpDoc's model significantly increases care delivery efficiency, reduces appointment wait times, and expands access to quality care, positioning it as a transformative player in value-based care for chronic disease patients in the U.S.

UpDoc is a healthcare technology company pioneering Remote Patient Intervention (RPI), a clinically tested, physician-supervised AI platform that manages chronic diseases through remote patient monitoring and conversational AI. The platform leverages advanced clinical intelligence and multi-LLM conversational interfaces, including partnerships with Microsoft and Google, to improve medication adherence and chronic disease management outcomes. UpDoc's model significantly increases care delivery efficiency, reduces appointment wait times, and expands access to quality care, positioning it as a transformative player in value-based care for chronic disease patients in the U.S.
Founded: 2023
Headquarters: Palo Alto, California
Product: Physician‑supervised Remote Patient Intervention (RPI) platform using agentic AI and conversational LLMs
Employees: ~10
Latest known funding: Seed (announced Jan 5, 2024)
Chronic disease management, remote patient monitoring, medication adherence, and value‑based care delivery
2023
Healthcare technology
Seed round announced Jan 5, 2024; five investors reported
“Polaris Partners lead; other reported investors include Pear VC, Oxeon Partners, Mayo Clinic, and Eli Lilly”